Ischemic stroke may activate bone marrow mononuclear cells to enhance recovery after stroke

Stem Cells and Development

Volumn 21, Issue 18, 2012, Pages 3332-3340

  Yang, Bing ^a   Xi, Xiaopei ^a   Aronowski, Jaroslaw ^a   Savitz, Sean I ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CD11B ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD71 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; THY 1 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW MONONUCLEAR CELL; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL ACTIVATION; CELL SUBPOPULATION; CONTROLLED STUDY; CONVALESCENCE; CORNER TEST; CYLINDER TEST; FLOW CYTOMETRY; FUNCTION TEST; LONG EVANS RAT; MALE; MESENCHYMAL STEM CELL; MIDDLE CEREBRAL ARTERY OCCLUSION; MONONUCLEAR CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD34; ANTIGENS, CD45; BONE MARROW CELLS; BRAIN; CELL COUNT; CELL DIFFERENTIATION; CHEMOKINE CCL2; HYPOXIA-ISCHEMIA, BRAIN; INTERLEUKIN-10; INTERLEUKIN-6; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE COUNT; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE CEREBRAL ARTERY; RATS; RATS, LONG-EVANS; STROKE; T-LYMPHOCYTES; TISSUE THERAPY; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; RATTUS; RODENTIA;

EID: 84870783623     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0037     Document Type: Article

References (21)

1. Stem Cell Therapies as an Emerging Paradigm in Stroke Participants. (2009). Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke 40:510-515.
2. Iihoshi S, O Honmou, K Houkin, K Hashi and JD Kocsis. (2004). A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res 1007:1-9.
3. Baker AH, V Sica, LM Work, S Williams-Ignarro, F de Nigris, LO Lerman, A Casamassimi, A Lanza, C Schiano, et al. (2007). Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemia. Proc Natl Acad Sci U S A 104:3597-3602.
4. Brenneman M, S Sharma, M Harting, R Strong, CS Cox, Jr., J Aronowski, JC Grotta and SI Savitz. (2010). Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J Cereb Blood Flow Metab 30:140-149.
5. Giraldi-Guimaraes A, M Rezende-Lima, FP Bruno and R Mendez-Otero. (2009). Treatment with bone marrow mononuclear cells induces functional recovery and decreases neurodegeneration after sensorimotor cortical ischemia in rats. Brain Res. 1266:108-120.
6. Denes A, Z Boldogkoi, G Uhereczky, A Hornyak, M Rusvai, M Palkovits and KJ Kovacs. (2005). Central autonomic control of the bone marrow: multisynaptic tract tracing by recombinant pseudorabies virus. Neuroscience 134:947-963.
7. Denes A, BW McColl, SF Leow-Dyke, KZ Chapman, NE Humphreys, RK Grencis, SM Allan and NJ Rothwell. (2011). Experimental stroke-induced changes in the bone marrow reveal complex regulation of leukocyte responses. J Cereb Blood Flow Metab 31:1036-1050.
8. Borlongan CV, TP Su and Y Wang. (2000). Treatment with delta opioid peptide enhances in vitro and in vivo survival of rat dopaminergic neurons. Neuroreport 11:923-926.
9. Theus MH, L Wei, L Cui, K Francis, X Hu, C Keogh and SP Yu. (2008). In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain. Exp Neurol 210:656-670.
10. Longa EZ, PR Weinstein, S Carlson and R Cummins. (1989). Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91.
11. Schallert T, SM Fleming, JL Leasure, JL Tillerson and ST Bland. (2000). CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39:777-787.
12. Yang B, R Strong, S Sharma, M Brenneman, K Mallikarjunarao, X Xi, JC Grotta, J Aronowski and SI Savitz. (2011). Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke. J Neurosci Res 89:833-839.
13. Rosen AB, DJ Kelly, AJ Schuldt, J Lu, IA Potapova, SV Doronin, KJ Robichaud, RB Robinson, MR Rosen, et al. (2007). Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis. Stem Cells 25:2128-2138.
14. Harting M, F Jimenez, S Pati, J Baumgartner and C Cox, Jr. (2008). Immunophenotype characterization of rat mesenchymal stromal cells. Cytotherapy 10:243-253.
15. Sharma S, B Yang, R Strong, X Xi, M Brenneman, JC Grotta, J Aronowski and SI Savitz. (2010). Bone marrow mononuclear cells protect neurons and modulate microglia in cell culture models of ischemic stroke. J Neurosci Res 88:2869-2876.
16. Zacharek A, A Shehadah, J Chen, X Cui, C Roberts, M Lu and M Chopp. (2010). Comparison of bone marrow stromal cells derived from stroke and normal rats for stroke treatment. Stroke 41:524-530.
17. Majka M, A Janowska-Wieczorek, J Ratajczak, K Ehrenman, Z Pietrzkowski, MA Kowalska, AM Gewirtz, SG Emerson and MZ Ratajczak. (2001). Numerous growth factors, cytokines, and chemokines are secreted by human CD34 (+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 97:3075-3085.
18. Taguchi A, T Soma, H Tanaka, T Kanda, H Nishimura, H Yoshikawa, Y Tsukamoto, H Iso, Y Fujimori, et al. (2004). Administration of CD34 + cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 114:330-338.
19. Shyu WC, SZ Lin, MF Chiang, CY Su and H Li. (2006). Intracerebral peripheral blood stem cell (CD34 +) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats. J Neurosci 26:3444-3453.
20. Nakano-Doi A, T Nakagomi, M Fujikawa, N Nakagomi, S Kubo, S Lu, H Yoshikawa, T Soma, A Taguchi and T Matsuyama. (2010). Bone marrow mononuclear cells promote proliferation of endogenous neural stem cells through vascular niches after cerebral infarction. Stem Cells 28:1292-1302.
21. Peterfalvi A, T Molnar, M Banati, G Pusch, E Miko, L Bogar, J Pal, L Szereday and Z Illes. (2009). Impaired function of innate T lymphocytes and NK cells in the acute phase of ischemic stroke. Cerebrovasc Dis 28:490-498.